Business Context and Reporting Period
Company: Nanophase Technologies Corporation (NANX)
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2003
Business Overview: Nanophase is a developer and commercial manufacturer of nanocrystalline materials (nanoparticles) used in sunscreens, personal care, chemical-mechanical planarization (CMP) for semiconductors, and polishing applications. The company operates manufacturing facilities in Romeoville and Burr Ridge, Illinois, utilizing Physical Vapor Synthesis (PVS) and NanoArc synthesis technologies.
Key Financial Metrics (Year Ended Dec 31, 2003)
| Metric | 2003 | 2002 |
|---|---|---|
| Total Revenue | $5,446,661 | $5,401,215 |
| Product Revenue | $4,880,313 | $5,002,986 |
| Other Revenue | $566,348 | $398,229 |
| Cost of Revenue | $5,205,065 | $5,095,019 |
| Gross Margin | 4.4% | 6.0% |
| Operating Loss | $(5,761,072) | $(5,120,852) |
| Net Loss | $(5,827,650) | $(5,155,237) |
| Loss Per Share (Basic/Diluted) | $(0.38) | $(0.35) |
| Cash & Cash Equivalents | $399,999 | $445,684 |
| Investments | $4,562,364 | $7,062,808 |
| Total Liquid Assets (Cash + Inv) | $4,962,363 | $7,508,492 |
| Long-Term Debt | $263,669 | $364,563 |
| Working Capital | $5,313,781 | $7,380,051 |
Material Changes vs. Prior Period
- Revenue Composition: Total revenue increased slightly (0.8%) to $5.45 million. However, core product revenue decreased by approximately $1.1 million due to reduced sales from the largest customer (BASF) and two other customers in abrasion-resistant and catalyst markets. This decline was partially offset by a $900,000 increase in revenue from RHEM (CMP market) and a one-time $226,450 sale of production equipment to CIK.
- Margins: Gross margin percentage declined from 6.0% in 2002 to 4.4% in 2003. Cost of revenue as a percentage of total revenue increased from 94% to 96%, primarily due to increased depreciation from facility build-outs and higher facility costs.
- Expenses: Research and Development (R&D) expenses increased to $1.91 million (from $1.57 million) due to increased salaries and product development costs. Selling, General, and Administrative (SG&A) expenses rose to $4.10 million (from $3.85 million) driven by legal fees related to securities litigation and insurance costs.
- Liquidity: Cash and investments decreased by approximately $2.5 million year-over-year, reflecting net cash used in operating activities of $4.45 million.
Guidance, Outlook, and Risks
- Outlook: Management expects increased demand for sunscreen and personal care materials in 2004. Revenue growth in the CMP and fine polishing markets is expected to begin in 2005. The company anticipates continuing to reduce manufacturing costs but may not operate at a positive gross margin in 2004.
- Capital Raising: On March 23, 2004 (subsequent to year-end), the company received $10 million in equity investment from Altana Chemie, AG. The company also filed a shelf registration statement to offer up to $15 million in securities.
- Key Risks:
- Customer Concentration: Three customers (BASF, RHEM, and CIK) accounted for approximately 94% of 2003 revenue. Loss of any single customer could materially harm operations.
- Financial Covenants: The supply agreement with BASF contains covenants requiring the company to maintain at least $2.0 million in cash/investments and limit debt to $10.0 million. Failure to meet these could trigger a mandatory transfer of technology and equipment to BASF.
- Profitability: The company has incurred cumulative losses of $45.7 million since inception and expects to continue incurring losses through at least the end of 2004.
Investor Verification Checklist
- Verify the status of the $10 million Altana equity investment and the terms of the joint development agreement.
- Confirm current cash balances against the $2.0 million covenant threshold in the BASF supply agreement.
- Assess the progress of revenue growth in the CMP market with RHEM, as this is a key growth driver for 2005.
- Review the timeline for the expiration of the Burr Ridge facility lease (September 2004) and potential renewal terms.
- Monitor the resolution of any ongoing or future securities litigation and associated insurance coverage.